Provivi
PrivateLast Round
Early Funding
Oct 28, 2026
Total Funding Raised
$260.25M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Provivi operates in Energy & Sustainability and is based in Santa Monica, California. Its latest recorded funding round was a VC Round in August 2024.
Provivi is an agtech company that develops pheromone-based insect control solutions for crop protection.
Sector
Energy & Sustainability
Verticals
Biotechnology, Clean Manufacturing
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Provivi Comparables
Compare Provivi with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| M2i Life Sciences | 84% | |
| ISCA | 81% | |
| Lithos Crop Protect GmbH | 81% |
For institutional investors. Book with your work email.
Provivi Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Oct 28, 2026 | ||||
| Early Stage VC | Sep 24, 2025 | ||||
| VC Round | Aug 19, 2024 | ||||
| Series C Extension | Feb 23, 2021 | ||||
| Series C Extension | Dec 22, 2020 | ||||
Debt | Jun 16, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Provivi Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Xeraya Capital | Series A |
| Temasek | Series C Extension, Series C |
| Kairos Ventures | Series A, Series C, Series C Extension, Series B, VC Round |
| Tybourne Capital Management | Series C Extension, Series C |
| Kairos Ventures | Series C, Series A, Seed, Series C Extension, VC Round, Series B |
| The Bill & Melinda Gates Foundation Trust | Series C Extension |
| Horizon Technology Finance Corporation | Debt |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 28, 2026
Raised $3M in early funding.
- Jul 25, 2026
Monthly visitors increased 38% MoM.
For institutional investors. Book with your work email.
Provivi Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Provivi's valuation, stock price, and market status.
Is Provivi a public or private company?
Provivi is a private company.
What is the current stock price of Provivi?
Provivi is a private company, so its shares have no public market price. Caplight tracks Provivi's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Provivi worth (valuation)?
Valuation information for Provivi is not publicly available.
Can I buy Provivi stock?
Provivi shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Provivi's last funding round?
Provivi's most recent funding round was Early Funding on October 28, 2026.
Who are the main investors in Provivi?
Key investors in Provivi include Temasek, Kairos Ventures, Kairos Ventures, The Bill & Melinda Gates Foundation Trust, Horizon Technology Finance Corporation.
Will Provivi IPO soon?
No public IPO plans have been announced for Provivi.
How can I track Provivi secondary market activity?
Caplight tracks bids, offers, and trades in Provivi's shares on secondary markets.